These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11202565)

  • 1. Agarose enhances the viability of intraperitoneally implanted microencapsulated L929 fibroblasts.
    Lahooti S; Sefton MV
    Cell Transplant; 2000; 9(6):785-96. PubMed ID: 11202565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microencapsulation of normal and transfected L929 fibroblasts in a HEMA-MMA copolymer.
    Lahooti S; Sefton MV
    Tissue Eng; 2000 Apr; 6(2):139-49. PubMed ID: 10941209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making microencapsulation work: conformal coating, immobilization gels and in vivo performance.
    Sefton MV; May MH; Lahooti S; Babensee JE
    J Control Release; 2000 Mar; 65(1-2):173-86. PubMed ID: 10699279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascularization and improved in vivo survival of VEGF-secreting cells microencapsulated in HEMA-MMA.
    Vallbacka JJ; Sefton MV
    Tissue Eng; 2007 Sep; 13(9):2259-69. PubMed ID: 17523877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viability of hydroxyethyl methacrylate-methyl methacrylate-microencapsulated PC12 cells after omental pouch implantation within agarose gels.
    Fleming AJ; Sefton MV
    Tissue Eng; 2003 Oct; 9(5):1023-36. PubMed ID: 14633386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual delivery of placental growth factor and vascular endothelial growth factor from poly(hydroxyethyl methacrylate-co-methyl methacrylate) microcapsules containing doubly transfected luciferase-expressing L929 cells.
    Cheng D; Sefton MV
    Tissue Eng Part A; 2009 Aug; 15(8):1929-39. PubMed ID: 19125649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyethyl methacrylate-methyl methacrylate (HEMA-MMA) copolymers for cell microencapsulation: effect of HEMA purity.
    Feng M; Sefton MV
    J Biomater Sci Polym Ed; 2000; 11(5):537-45. PubMed ID: 10896046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of an immobilization matrix and capsule membrane permeability on the viability of encapsulated HEK cells.
    Lahooti S; Sefton MV
    Biomaterials; 2000 May; 21(10):987-95. PubMed ID: 10768750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viability of HEMA-MMA microencapsulated model hepatoma cells in rats and the host response.
    Babensee JE; Sefton MV
    Tissue Eng; 2000 Apr; 6(2):165-82. PubMed ID: 10941211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mouse VEGF164 on the viability of hydroxyethyl methacrylate-methyl methacrylate-microencapsulated cells in vivo: bioluminescence imaging.
    Cheng D; Lo C; Sefton MV
    J Biomed Mater Res A; 2008 Nov; 87(2):321-31. PubMed ID: 18181105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small agarose microcapsules with cell-enclosing hollow core for cell therapy: transplantation of Ifosfamide-activating cells to the mice with preestablished subcutaneous tumor.
    Sakai S; Hashimoto I; Tanaka S; Salmons B; Kawakami K
    Cell Transplant; 2009; 18(8):933-9. PubMed ID: 19500478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activity and proliferation of CHO cells in hydroxyethyl methacrylate-methyl methacrylate (HEMA-MMA) microcapsules.
    Uludag H; Sefton MV
    Cell Transplant; 1993; 2(2):175-82. PubMed ID: 8143082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host reaction against alginate-polylysine microcapsules containing living cells.
    Vandenbossche GM; Bracke ME; Cuvelier CA; Bortier HE; Mareel MM; Remon JP
    J Pharm Pharmacol; 1993 Feb; 45(2):121-5. PubMed ID: 8095526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoblot analysis of proteins associated with HEMA-MMA microcapsules: human serum proteins in vitro and rat proteins following implantation.
    Babensee JE; Cornelius RM; Brash JL; Sefton MV
    Biomaterials; 1998; 19(7-9):839-49. PubMed ID: 9663761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A biodegradable, immunoprotective, dual nanoporous capsule for cell-based therapies.
    Zhang X; He H; Yen C; Ho W; Lee LJ
    Biomaterials; 2008 Nov; 29(31):4253-9. PubMed ID: 18694595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selected aspects of the microencapsulation of mammalian cells in HEMA-MMA.
    Sefton MV; Hwang JR; Babensee JE
    Ann N Y Acad Sci; 1997 Dec; 831():260-70. PubMed ID: 9616718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 secretion increases signal persistence of HEMA-MMA-microencapsulated luciferase-modified CHO fibroblasts in mice.
    Surzyn M; Symes J; Medin JA; Sefton MV
    Tissue Eng Part A; 2009 Jan; 15(1):127-36. PubMed ID: 18710337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alginate encapsulation of genetically engineered mammalian cells: comparison of production devices, methods and microcapsule characteristics.
    Koch S; Schwinger C; Kressler J; Heinzen Ch; Rainov NG
    J Microencapsul; 2003; 20(3):303-16. PubMed ID: 12881112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine secretion by PC12 cells microencapsulated in a hydroxyethyl methacrylate--methyl methacrylate copolymer.
    Roberts T; De Boni U; Sefton MV
    Biomaterials; 1996 Feb; 17(3):267-75. PubMed ID: 8745323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformal coating of mammalian cells immobilized onto magnetically driven beads.
    Khademhosseini A; May MH; Sefton MV
    Tissue Eng; 2005; 11(11-12):1797-806. PubMed ID: 16411825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.